CITR on NYSE
CitroTech Inc.
American chemicals and allied products company, incorporated in Wyoming. Summary from the record
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with LIQUIDMETAL TECHNOLOGIES INC, BIOLARGO, INC. or Loop Industries, Inc., or pick any stock.
- TickerCITR on NYSE1
- IndustryChemicals & Allied Products1
- HeadquartersGreenwood Village, Colorado1
- Incorporated inWY2
- Business address6400 S. Fiddlers Green Cir, Suite 300, Greenwood Village, Co 801112
- Filer categoryNon-accelerated filer, Smaller reporting company2
See how the biggest companies compare on our leaderboards
Financial Officer; Steve Conboy, Chief Technical Officer and Anthony Newton, General Counsel.3 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Products Sale brought in 57% of the revenue CitroTech Inc. broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2024 | 2025 |
|---|---|---|
| Products Sale | $626.4K | $1.3M |
| Product Installation Service | $182.0K | $1.0M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue52¢$1.9M
- Research and development6¢$198.5K
- Interest42¢$1.5M
Out of $2.4M in revenue.4 The company lost money this year.
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenue | $2.4M | $808.4K |
| Cost of revenue, exclusive of amortization and depreciation shown separately below | $1.8M | $554.2K |
| Cost of revenue - related parties | $60.3K | $101.3K |
| Amortization and depreciation | $329.3K | $264.7K |
| General and administration | $1.6M | $498.4K |
| Advertising and marketing | $673.6K | $1.0M |
| Payroll and management compensation | $9.9M | $75.0K |
| Professional fees | $2.2M | $3.0M |
| Professional fees - related parties | $2.2M | $589.3K |
| Research and development expense | $198.5K | $14.0K |
| Total operating expenses | $18.9M | $6.1M |
| Loss from operations | -$16.5M | -$5.3M |
| Other income | $600 | $0 |
| Interest expense | -$1.5M | -$257.8K |
| Interest expense - related parties | -$1.3M | $0 |
| Interest income | $26.9K | $0 |
| Financing expense | -$6.2M | $0 |
| Financing expense - related party | -$2.5M | $0 |
| Loss on fair value of derivative liability | -$2.0M | -$409.8K |
| Loss on settlement of debt | -$6.8M | -$909.5K |
| Total other expense | -$20.3M | -$1.6M |
| Loss before taxes | -$36.8M | -$6.9M |
| Provision for income taxes | $0 | $0 |
| Net loss | -$36.8M | -$6.9M |
| Comprehensive loss | -$36.8M | -$6.9M |
| Net loss per common share - basic | -$2.96 | -$0.82 |
| Net loss per common share - diluted | -$2.96 | -$0.82 |
| Weighted average number of common shares outstanding - basic | 12.4M shares | 8.4M shares |
| Weighted average number of common shares outstanding - diluted | 12.4M shares | 8.4M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 5 fiscal years (annual) or 5 quarters (quarterly), latest first.4
| Period ending | 2025-12-31 | 2025-03-31 | 2025-01-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|---|---|
| Cash | $6.3M | $775.1K | |||
| Accounts receivable, net | $209.0K | $317.5K | |||
| Inventory | $620.8K | $324.7K | |||
| Prepaid expenses | $317.0K | $74.1K | |||
| Deferred offering costs | $0 | $126.1K | |||
| Total Current Assets | $7.4M | $1.6M | |||
| Intangible assets, net | $5.3M | $3.7M | |||
| Operating lease right-of-use asset | $753.4K | $49.3K | |||
| Equipment, net | $630.3K | $111.4K | |||
| Security deposit | $57.5K | $37.0K | $0 | ||
| Total Non-Current Assets | $6.8M | $3.9M | |||
| Total Assets | $14.2M | $5.5M | |||
| Accounts payable and accrued liabilities | $316.3K | $187.0K | |||
| Deferred revenue | $3.0K | $0 | |||
| Convertibles notes, net of discount | $219.3K | $196.1K | |||
| Convertibles notes, net of discount - related parties | $1.3M | $576.7K | |||
| Due to related parties | $168.0K | $0 | |||
| Financing loan - current portion | $30.0K | $96.8K | |||
| Derivative liability | $0 | $1.1M | |||
| Operating lease liability - current portion | $147.6K | $50.0K | |||
| Total Current Liabilities | $2.2M | $2.2M | |||
| Financing loan | $133.4K | $0 | |||
| Operating lease liability | $617.6K | $0 | |||
| Total Non-Current Liabilities | $751.0K | $0 | |||
| Total Liabilities | $2.9M | $2.2M | |||
| Common Stock, par value $0.0001, authorized 1,000,000,000 shares, 18,522,315 and 6,140,264 issued and outstanding, respectively | $1.9K | $614 | |||
| Additional paid-in capital | $124.5M | $79.7M | |||
| Accumulated deficit | -$113.2M | -$76.4M | |||
| Total Stockholders' Equity | $11.3M | $3.3M | $3.6M | ||
| Total Liabilities and Stockholders' Equity | $14.2M | $5.5M | |||
| Preferred stock, par value | $0.00 | $0.00 | $0.00 | ||
| Preferred stock, shares authorized | 30.0M shares | 30.0M shares | 30.0M shares | ||
| Common stock, par value | $0.00 | $0.00 | |||
| Common stock, shares authorized | 1.0B shares | 1.0B shares | 1.0B shares | ||
| Common stock, shares issued | 18.5M shares | 6.1M shares | |||
| Common stock, shares outstanding | 18.5M shares | 6.1M shares |
| Period ending | 2025-12-31 | 2025-03-31 | 2025-01-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|---|---|
| Cash | $6.3M | $775.1K | |||
| Accounts receivable, net | $209.0K | $317.5K | |||
| Inventory | $620.8K | $324.7K | |||
| Prepaid expenses | $317.0K | $74.1K | |||
| Deferred offering costs | $0 | $126.1K | |||
| Total Current Assets | $7.4M | $1.6M | |||
| Intangible assets, net | $5.3M | $3.7M | |||
| Operating lease right-of-use asset | $753.4K | $49.3K | |||
| Equipment, net | $630.3K | $111.4K | |||
| Security deposit | $57.5K | $37.0K | $0 | ||
| Total Non-Current Assets | $6.8M | $3.9M | |||
| Total Assets | $14.2M | $5.5M | |||
| Accounts payable and accrued liabilities | $316.3K | $187.0K | |||
| Deferred revenue | $3.0K | $0 | |||
| Convertibles notes, net of discount | $219.3K | $196.1K | |||
| Convertibles notes, net of discount - related parties | $1.3M | $576.7K | |||
| Due to related parties | $168.0K | $0 | |||
| Financing loan - current portion | $30.0K | $96.8K | |||
| Derivative liability | $0 | $1.1M | |||
| Operating lease liability - current portion | $147.6K | $50.0K | |||
| Total Current Liabilities | $2.2M | $2.2M | |||
| Financing loan | $133.4K | $0 | |||
| Operating lease liability | $617.6K | $0 | |||
| Total Non-Current Liabilities | $751.0K | $0 | |||
| Total Liabilities | $2.9M | $2.2M | |||
| Common Stock, par value $0.0001, authorized 1,000,000,000 shares, 18,522,315 and 6,140,264 issued and outstanding, respectively | $1.9K | $614 | |||
| Additional paid-in capital | $124.5M | $79.7M | |||
| Accumulated deficit | -$113.2M | -$76.4M | |||
| Total Stockholders' Equity | $11.3M | $3.3M | $3.6M | ||
| Total Liabilities and Stockholders' Equity | $14.2M | $5.5M | |||
| Preferred stock, par value | $0.00 | $0.00 | $0.00 | ||
| Preferred stock, shares authorized | 30.0M shares | 30.0M shares | 30.0M shares | ||
| Common stock, par value | $0.00 | $0.00 | |||
| Common stock, shares authorized | 1.0B shares | 1.0B shares | 1.0B shares | ||
| Common stock, shares issued | 18.5M shares | 6.1M shares | |||
| Common stock, shares outstanding | 18.5M shares | 6.1M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss | -$36.8M | -$6.9M |
| Stock-based compensation | $14.5M | $2.7M |
| Stock-based compensation - related parties | $4.6M | $348.0K |
| Bad debt expense | $345.9K | $22.8K |
| Non-cash lease expenses | $161.2K | $80.3K |
| Amortization and depreciation | $329.3K | $264.7K |
| Amortization of debt discount | $2.4M | $196.1K |
| Loss on settlement of debt | $6.8M | $909.5K |
| Loss on fair value of derivative liability | $2.0M | $409.8K |
| Write off of deferred offering costs | $197.4K | $0 |
| Accounts receivable | -$237.5K | $87.2K |
| Inventory | -$370.9K | -$94.5K |
| Prepaid expenses | -$242.9K | -$63.5K |
| Security deposit | -$57.5K | $0 |
| Accounts payable and accrued liabilities | $343.8K | $147.3K |
| Related party advances funding operating expense | $25.3K | $6.5K |
| Accrued interest - related parties | $223.1K | $0 |
| Deferred revenue | $3.0K | $0 |
| Operating lease liabilities | -$150.1K | -$80.1K |
| Net Cash used in Operating Activities | -$5.9M | -$1.9M |
| Purchase of equipment | -$194.0K | $0 |
| Acquisition of intangible asset | -$100.0K | $0 |
| Net Cash used in Investing Activities | -$294.0K | $0 |
| Proceeds from convertible notes and warrants | $1.9M | $1.2M |
| Proceeds from convertible note and warrants - related party | $1.8M | $0 |
| Payments of deferred offering costs | -$71.3K | -$126.1K |
| Proceeds from loan - related party | $0 | $2.0K |
| Repayment of loan - related party | -$25.0K | -$740.9K |
| Proceeds from issuance of Series C Convertible Preferred Stock and warrants | $8.3M | $1.8M |
| Repayment of financing loan | -$265.0K | -$23.3K |
| Net Cash provided by Financing Activities | $11.7M | $2.2M |
| Change in cash | $5.5M | $225.4K |
| Cash paid for interest | $13.0K | $9.2K |
| Cash paid for taxes | $0 | $0 |
| Common stock issued for services | $0 | $1.9M |
| Series C Convertible Preferred stock issued for services | $0 | $1.2M |
| Common stock issued upon conversion of Series C Convertible Preferred stock | $1.1K | $0 |
| Common stock issued for conversion and settlement of debt | $11.5M | $1.1M |
| Common stock issued for stock to be issued - management | $0 | $180.0K |
| Stock payable for acquisition of intangible asset | $1.8M | $0 |
| Series C Convertible Preferred stock issued for subscription received | $0 | $500.0K |
| Cancellation of common stock - related party | $0 | $6.5K |
| Warrants issued in conjunction with convertible debts | $882.0K | $546.9K |
| Right -of-use assets obtained in exchange for new operating lease liabilities | $865.2K | $0 |
| Recognition of derivative liability as debt discount | $1.0M | $645.5K |
| Reclassification of derivative liability to additional paid-in capital | $1.6M | $0 |
| Transfer from inventory to property and equipment | $74.8K | $0 |
| Acquisition of property and equipment as financing loan | $331.5K | $120.2K |
No quarter-by-quarter statement was filed.
Leadership
Who has led CitroTech Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
Chief operating officer
- Chief executive officerWesley James Bolsen Feb 17, 2026 to now13
- Chief executive officerTheodore Ralston Sep 23, 2025 to Feb 17, 202614
- Chief executive officerJoshua Eugene Ralston Dec 5, 2024 to Dec 5, 202415
- Chief executive officerTimothy J. Koziol May 16, 2007 to Jul 13, 200916
- PresidentTheodore Ralston Sep 23, 2025 to now14
- PresidentJoshua Eugene Ralston Dec 5, 2024 to Dec 5, 202415
- Chief financial officerNanuk Warman Apr 16, 2025 to now17
- Chief financial officerBrett Maxwell Clark May 16, 2007 to Jul 13, 200918
- Chief operating officerAndrew Hotsko Feb 24, 2026 to now19
Board members and other officers (13)
- Chief Technology OfficerStephen Conboy Sep 23, 2025 to now20
- SecretaryClyde E. Rhodes Jr. May 29, 2007 to Jul 13, 200921
- Board memberWesley James Bolsen Feb 17, 2026 to now13
- Board memberCraig A. Huff Feb 18, 2026 to now22
- Board memberLorenzo Calinawan Mar 2, 2026 to now23
- Board memberJeffery Bruce Pomerantz Mar 3, 2026 to now24
- Board memberMichael M. Feigin Jul 21, 2026 to now25
- Board memberTheodore Ralston Sep 23, 2025 to now14
- Board memberJoshua Eugene Ralston Dec 5, 2024 to Dec 5, 202415
- Board memberJames P. Stapleton Apr 9, 2007 to May 16, 200726
- Board memberTimothy J. Koziol May 16, 2007 to Jul 13, 200916
- Board memberClyde E. Rhodes Jr. May 29, 2007 to Jul 13, 200921
- General counselAnthony F. Newton Mar 18, 2026 to now27
Former names
Timeline
Filings
207 filings to the SEC since October 2021: 16 annual reports, 52 quarterly reports, 26 major events, 58 insider forms, 9 large holders, 46 other. The latest 20:
- Oct 5, 20264 EDGAR
- Oct 1, 2026S-1/A AMENDMENT NO 1 EDGAR
- Sep 28, 2026S-1 REGISTRATION STATEMENT EDGAR
- Sep 14, 20268-K EDGAR
- Aug 28, 2026DRS EDGAR
- Aug 10, 202610-Q/A FORM 10-Q FOR JUN 2026, AMENDMENT 1 EDGAR
- Aug 10, 202610-Q FORM 10-Q FOR JUN 2026 EDGAR
- Aug 6, 2026SCHEDULE 13D/A EDGAR
- Aug 6, 20264 EDGAR
- Jul 29, 20264 EDGAR
- Jul 21, 20263 PRIMARY DOCUMENT EDGAR
- Jun 17, 20268-K EDGAR
- Jun 12, 20264 EDGAR
- Jun 5, 20264 EDGAR
- Jun 3, 2026SCHEDULE 13D/A EDGAR
- Jun 3, 2026S-8 REGISTRATION STATEMENT EDGAR
- Jun 1, 20264 EDGAR
- Jun 1, 20263 EDGAR
- Jun 1, 20268-K EDGAR
- Jun 1, 20264 EDGAR
The 207 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
228 open-market trades by officers, directors and large owners since October 2021: 198 buys and 30 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 4, 2026 | Conboy Stephen | Sale | 275,001 | $3.00 | $825.0K | Form 4 |
| Mar 20, 2025 | Ralston TheodoreDirector | Buy | 83 | $7.42 | $616 | Form 4 |
| Mar 19, 2025 | Ralston TheodoreDirector | Buy | 449 | $7.12 | $3.2K | Form 4 |
| Mar 18, 2025 | Ralston Joshua Eugene | Sale | 250,000 | $2.40 | $600.0K | Form 4 |
| Mar 18, 2025 | Ralston TheodoreDirector | Buy | 1,183 | $7.17 | $8.5K | Form 4 |
| Mar 18, 2025 | Ralston TheodoreDirector | Sale | 9,167 | $7.50 | $68.8K | Form 4 |
| Mar 17, 2025 | Ralston TheodoreDirector | Buy | 34 | $7.62 | $259 | Form 4 |
| Mar 17, 2025 | Ralston TheodoreDirector | Sale | 13,584 | $7.50 | $101.9K | Form 4 |
| Mar 14, 2025 | Ralston TheodoreDirector | Buy | 665 | $6.64 | $4.4K | Form 4 |
| Mar 13, 2025 | Ralston TheodoreDirector | Buy | 34 | $7.07 | $240 | Form 4 |
| Mar 12, 2025 | Ralston TheodoreDirector | Buy | 205 | $7.41 | $1.5K | Form 4 |
| Mar 12, 2025 | Ralston TheodoreDirector | Buy | 497 | $7.14 | $3.5K | Form 4 |
| Mar 12, 2025 | Ralston TheodoreDirector | Sale | 22,140 | $7.31 | $161.8K | Form 4 |
| Mar 11, 2025 | Ralston TheodoreDirector | Buy | 51 | $8.60 | $439 | Form 4 |
| Mar 11, 2025 | Ralston TheodoreDirector | Sale | 50 | $8.70 | $435 | Form 4 |
| Mar 10, 2025 | Ralston TheodoreDirector | Buy | 33 | $8.58 | $283 | Form 4 |
| Mar 10, 2025 | Ralston TheodoreDirector | Sale | 50 | $8.61 | $430 | Form 4 |
| Mar 10, 2025 | Ralston TheodoreDirector | Sale | 1,866 | $8.35 | $15.6K | Form 4 |
| Mar 7, 2025 | Ralston TheodoreDirector | Sale | 20 | $8.58 | $172 | Form 4 |
| Mar 6, 2025 | Ralston TheodoreDirector | Buy | 34 | $7.62 | $259 | Form 4 |
All 228 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Stephen ConboySCHEDULE 13D/A, 2 filings Apr 15, 2025 to Aug 6, 202628
- Theodore RalstonSCHEDULE 13D/A, 3 filings Mar 24, 2025 to Jun 3, 202629
- BoltRock Holdings LLCSCHEDULE 13D/A, 4 filings Mar 24, 2025 to Jun 1, 202630
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.
13F reports cover disclosed long positions in U.S. stocks only.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARCitroTech Inc. filings on SEC EDGAR
- 2SEC EDGARCitroTech Inc. filings on SEC EDGAR
- 3
- 4SEC EDGARCitroTech Inc. 10-K for fiscal 2025
- 5SEC EDGARCitroTech Inc. 10-K for fiscal 2021
- 6SEC EDGARCitroTech Inc. 10-K for fiscal 2022
- 7SEC EDGARCitroTech Inc. 10-K for fiscal 2023
- 8SEC EDGARCitroTech Inc. 10-K for fiscal 2020
- 9SEC EDGARCitroTech Inc. 10-K for fiscal 2022
- 10SEC EDGARCitroTech Inc. 10-K for fiscal 2019
- 11SEC EDGARCitroTech Inc. 10-Q for fiscal 2026
- 12SEC EDGARCitroTech Inc. 10-Q for fiscal 2026
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21SEC EDGARClyde E. Rhodes Jr., Secretary
- 22SEC EDGARCraig A. Huff, Board member
- 23SEC EDGARLorenzo Calinawan, Board member
- 24
- 25SEC EDGARMichael M. Feigin, Board member
- 26SEC EDGARJames P. Stapleton, Board member
- 27SEC EDGARAnthony F. Newton, General counsel
- 28
- 29
- 30